JESSICA STOMBAUGH: Open Payments
NPI 1992473755 · LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,666 in 96 payments from 24 companies in 2025. Trend: 2023 $1,952 · 2024 $1,909 · 2025 $1,666
Food & beverage: $1,666
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $355 |
| PFIZER INC. | 10 | $138 |
| Amneal Pharmaceuticals LLC | 4 | $99 |
| Neurocrine BioSciences, Inc. | 4 | $93 |
| Teva Pharmaceuticals USA, Inc. | 5 | $92 |
| Axsome Therapeutics, Inc. | 4 | $91 |
| Amgen Inc. | 5 | $88 |
| ARGENX US, INC. | 4 | $86 |
| Lundbeck LLC | 4 | $67 |
| ACADIA Pharmaceuticals Inc | 3 | $65 |
Products named: UBRELVY, NURTEC ODT, CREXONT, QULIPTA, INGREZZA, AUSTEDO XR, Sunosi, UPLIZNA.
Industry payments across IN — which companies pay providers there.
